Skip links
Aptar Digital Health and Legit.Health Partner to Improve Patient Experience in Immuno-Dermatology

Aptar Digital Health and Legit.Health Partner to Improve Patient Experience in Immuno-Dermatology

Collaboration will integrate Legit.Health’s innovative technology into Aptar Digital Health’s proprietary digital health platform to better manage and treat skin conditions

Aptar Digital Health, a global expert in Software as a Medical Device (SaMD), digital Patient Support Programs (PSPs) and disease management solutions, today announced a new partnership with Legit.Health, an innovative artificial intelligence (AI)-based medical device (CE-marked) software company, which aims to transform patient care and increase patient adherence to better manage skin conditions.

Legit.Health’s state-of-the-art technology, which supports the diagnosis of approximately 300 conditions, including atopic dermatitis, psoriasis and skin cancer, will be integrated into Aptar’s Digital Health proprietary platform. Focused on enhancing patient care and increasing patient autonomy, this advanced digital solution will support healthcare professionals (HCPs) to diagnose skin conditions earlier and will enable patients to start sooner on treatment plans to improve their overall quality of life. The solution may also be used to facilitate patient enrolment in clinical trials.

Legit.Health’s use of AI for monitoring disease progression through automated, clinically validated scoring systems such as the Psoriasis Area Severity Index (PASI) and SCORing Atopic Dermatitis (SCORAD) will be leveraged within this partnership. This will help to ensure patients receive the most accurate and timely information to manage and treat their skin condition more effectively. The AI-powered technology also extends to the quantification of the intensity, count and extent of the visible clinical signs of skin conditions, offering HCPs a more precise measure of disease severity, an indicator considered critical in determining the most appropriate treatment.

This strategic partnership is set to drive digital transformation in the healthcare sector. The combined expertise of Aptar Digital Health and Legit.Health will pave the way towards harnessing the power of AI to improve patient experiences and outcomes in immuno-dermatology.

Sai Shankar, President, Aptar Digital Health, stated, “Since 2021, Aptar Digital Health has been growing our portfolio of technology partners to provide improved solutions for patients in multiple therapeutic areas such as cardiology, neurology and visual acuity. With this new partnership, Aptar Digital Health is acquiring the ability to leverage AI technology to accelerate the diagnosis and monitoring of skin conditions.”

Andy Aguilar, CEO and Co-Founder of Legit.Health, commented, “One of our main aims within the medical assistance process in the field of dermatology is to be able to offer patients the opportunity of having the earliest and most accurate diagnosis, with the appropriate referral and treatment to reduce uncertainty and waiting times.” She added, “Legit.Health’s technology helps the medical practitioner to provide this kind of care to their patients and today, thanks to our partnership with Aptar Digital Health, we will be able to reach even more people who will benefit from our service.”

About Legit.Health

Legit.Health is the revolutionary dermatological application based on artificial intelligence and Deep Learning technology, designed for Next-generation dermatologists. Health professionals who take advantage of the opportunities offered by new technologies to improve the state of the art in their field.

The algorithms were designed by Legit.Health is capable of, through simple photography, automatically fill-in most of the medical grading systems, such as PASISCORADUASGAGS, and many more dermatology scoring systems. Becoming the tool that makes life easier for many doctors and patients. ​​In addition, the data is highly protected and stored in an encrypted system. 

Legit.Health helps Next-generation dermatologists to offer a diagnosis much faster than the one achieved traditionally, reducing the workload of the doctor allowing them to estimate the severity of the pathology in a faster way and supporting their knowledge by offering an objective diagnosis.

In short, a tool that combines objectivity and precision in the report of a pathology and that allows doctors to maintain daily and effective communication with their patients. As well as being constantly informed of the changes in the pathology of the patient.

About Aptar Digital Health

Aptar Pharma’s Digital Health division is part of AptarGroup, Inc., a global leader in drug and consumer product dosing, dispensing and protection technologies. Aptar Digital Health creates end-to-end solutions to enhance patient experiences every day, leveraging a holistic ecosystem of digital interventions. Amplified by an industry-leading portfolio of products and solutions, Aptar Digital Health’s offering combines mobile and web apps, connected drug delivery systems, onboarding, training and advanced data analytics services to actively empower patients and create a positive treatment journey. Aptar is headquartered in Crystal Lake, Illinois and has 13,500 dedicated employees in 20 countries. For more information, please visit www.aptardigitalhealth.com and www.aptar.com.